{"id":"gallium-67ga-citrate","rwe":[{"pmid":"30000617","year":"2006","title":"Gallium Citrate Ga 67.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"29319141","year":"2018","title":"The use of 67Ga scintigraphy in patients with sarcoidosis.","finding":"","journal":"Nuclear medicine review. Central & Eastern Europe","studyType":"Clinical Study"},{"pmid":"19839896","year":"2009","title":"Lacrimal gland uptake of gallium (67Ga) citrate in patients without ocular pathology.","finding":"","journal":"Orbit (Amsterdam, Netherlands)","studyType":"Clinical Study"},{"pmid":"8929386","year":"1996","title":"Pulmonary gallium-67 uptake in diffuse pulmonary calcinosis.","finding":"","journal":"Pediatric radiology","studyType":"Clinical Study"},{"pmid":"3580352","year":"1987","title":"Assessment of activity of ocular sarcoidosis by gallium scanning.","finding":"","journal":"The British journal of ophthalmology","studyType":"Clinical Study"}],"tags":[{"label":"Radioactive Diagnostic Agent","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"V09HX01","category":"atc"},{"label":"Intravenous","category":"route"},{"label":"Injection","category":"form"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{"commonSideEffects":[{"effect":"Severe itching","drugRate":"≥1/300 (0.33%)","severity":"mild"},{"effect":"Erythema","drugRate":"≥1/300 (0.33%)","severity":"mild"},{"effect":"Rash","drugRate":"≥1/300 (0.33%)","severity":"mild"},{"effect":"Hypersensitivity reactions","drugRate":"reported","severity":"unknown"},{"effect":"Allergic reactions","drugRate":"reported","severity":"unknown"},{"effect":"Nausea","drugRate":"reported","severity":"unknown"}],"specialPopulations":{"Pregnancy":"Gallium Citrate Ga 67 Injection should be given to pregnant woman only if clearly needed.","Geriatric use":"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant diseases which may cause a reduction in hepatic, renal, or cardiac function.","Paediatric use":"Safety and effectiveness in the pediatric population has not been established.","Hepatic impairment":"decreased hepatic, renal, or cardiac function"}},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"gallium-67 citrate","offLabel":[],"synonyms":["gallium citrate Ga-67","gallium (67Ga) citrate","gallium-67 citrate"],"timeline":[],"approvals":[],"brandName":"Gallium-67 Citrate","ecosystem":[],"mechanism":{"moaClass":"Radiopharmaceutical Activity","modality":"Small Molecule","drugClass":"Radioactive Diagnostic Agent","explanation":"Imagine your body as a city with different buildings. Gallium-67 Citrate is like a special flashlight that shines on certain buildings, making them visible on a scan. This helps doctors see what's going on inside the body and make diagnoses.","oneSentence":"Gallium-67 Citrate works by emitting gamma rays that are absorbed by certain tissues, allowing for imaging of the body.","technicalDetail":"Gallium-67 Citrate is a radioactive isotope of gallium that is chelated to citrate, allowing it to be taken up by certain cells and tissues, which are then visualized using gamma camera imaging."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4560","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=gallium%20%2867Ga%29%20citrate","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=gallium (67Ga) citrate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:55:49.728504","biosimilars":[],"competitors":[],"genericName":"gallium (67ga) citrate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04139395","phase":"PHASE3","title":"68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)","status":"WITHDRAWN","sponsor":"Carina Mari Aparici","startDate":"2019-01-15","conditions":["Fever of Unknown Origin"],"enrollment":0,"completionDate":"2021-12-20"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Intravenous","formulation":"Injection","formulations":[{"form":"INJECTION","route":"INTRAVENOUS","productName":"Gallium"}]},"crossReferences":{"NUI":"N0000146515","MMSL":"20978","NDDF":"009823","UNII":"4LJK511Z86","VUID":"4018180","CHEBI":"CHEBI:31645","VANDF":"4018180","INN_ID":"3744","RXNORM":"272758","UMLSCUI":"C0893383","ChEMBL_ID":"CHEMBL1200994","DRUGBANK_ID":"DB06784","PUBCHEM_CID":"65430"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":7,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"V09HX01","allCodes":["V09HX01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2006","pmid":"30000617","title":"Gallium Citrate Ga 67.","journal":""},{"date":"2018","pmid":"29319141","title":"The use of 67Ga scintigraphy in patients with sarcoidosis.","journal":"Nuclear medicine review. Central & Eastern Europe"},{"date":"2009","pmid":"19839896","title":"Lacrimal gland uptake of gallium (67Ga) citrate in patients without ocular pathology.","journal":"Orbit (Amsterdam, Netherlands)"},{"date":"1996 Nov","pmid":"8929386","title":"Pulmonary gallium-67 uptake in diffuse pulmonary calcinosis.","journal":"Pediatric radiology"},{"date":"1987 May","pmid":"3580352","title":"Assessment of activity of ocular sarcoidosis by gallium scanning.","journal":"The British journal of ophthalmology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Gallium-67 Citrate is a radioactive diagnostic agent used for imaging purposes. It is a small molecule that targets unknown areas of the body. The commercial status of Gallium-67 Citrate is unclear, and it may be patented or generic. Key safety considerations include radiation exposure and potential side effects. Further information on its approved indications, half-life, and bioavailability is not available.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}